{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:23:55Z","timestamp":1790774635347,"version":"4.1.0"},"reference-count":97,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recurrence invariably occurs in patients with high-grade glioma (HGG) despite maximal definitive therapy. Currently, there is no standard-of-care salvage treatment approach and re-irradiation is considered an option for select patients. Various radiotherapy fractionation schedules have been investigated, including the use of stereotactic radiosurgery (SRS). The aim of this study was to provide clinical practice recommendations on behalf of the International Stereotactic Radiosurgery Society (ISRS) specific to salvage SRS for recurrent-HGG. We define SRS as focal radiation in a single fraction and hypofractionated radiosurgery (HFSRS) as focal radiation delivered over 2-5 fractions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A literature review and meta-analysis were performed according to PRISMA guidelines. Recommendations were formulated according to DELPHI methodology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sixty-two studies met the eligibility criteria for analyses, resulting in 2640 recurrent HGG patients. Stereotactic radiosurgery to a median total dose of 16 Gy was performed in 75% of patients, and HFSRS to the remaining 25% with a median total dose and number of fractions of 25 Gy and 5 fractions, respectively. The median overall survival from re-irradiation was 10.2 months. The pooled neurological toxicity rates were lower with HFSRS compared to SRS (4% vs. 7%, P\u2009=\u20090.001). A cumulative EQD2 greater than 120-130 Gy was significantly associated with a greater risk of radiation necrosis (P\u2009=\u20090.003).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Focal re-irradiation with 16 Gy in single fraction or 24-25 Gy in 3-5 fractions, is safe and appears to be effective for recurrent-HGG. We also present clinical practice recommendations on behalf of the ISRS. Given the limited prospective data, no definitive conclusions can be drawn.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuonc\/noaf247","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T11:48:06Z","timestamp":1761133686000},"page":"353-370","source":"Crossref","is-referenced-by-count":3,"title":["International Stereotactic Radiosurgery Society (ISRS) practice guidelines for radiosurgery in recurrent high-grade glioma"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0889-3371","authenticated-orcid":false,"given":"Valentina","family":"Pinzi","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Unit of Radiotherapy, Fondazione IRCCS Istituto Neurologico C Besta , Milan, Italy (V.P., L.F.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6927-0402","authenticated-orcid":false,"given":"Rupesh","family":"Kotecha","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida , Miami, Florida (R.K.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Sahgal","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto , Toronto, Ontario, Canada (A.S.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Gorgulho","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, State University of S\u00e3o Paulo, NeuroSapiens Group , S\u00e3o Paulo, Brazil (A.G.)"},{"name":"D\u2019Or Institute for Research and Education , S\u00e3o Paulo, Brazil (A.G.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jane","family":"Lim-Fat","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto , Toronto, Ontario, Canada (M.J.L.-F.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Levivier","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, Neurosurgery Service and Gamma Knife Center, Centre Hospitalier Universitaire Vaudois , Lausanne, Switzerland (M.L.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Southern California , Los Angeles, California (L.M.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3820-8654","authenticated-orcid":false,"given":"Ian","family":"Paddick","sequence":"additional","affiliation":[{"name":"Queen Square Radiosurgery Centre, National Hospital for Neurology and Neurosurgery , London, UK (I.P.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Regis","sequence":"additional","affiliation":[{"name":"Aix-Marseille Universit\u00e9, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, Institut de Neurosciences des Syst\u00e8mes (INS) UMR1106 , Marseille, France (J.R.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason P","family":"Sheehan","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University of Virginia , Charlottesville, Virginia (J.P.S.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H","family":"Suh","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic , Cleveland, Ohio (J.H.S.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Yomo","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, Aizawa Comprehensive Cancer Center, Aizawa Hospital , Matsumoto, Japan (S.Y.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Fariselli","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Unit of Radiotherapy, Fondazione IRCCS Istituto Neurologico C Besta , Milan, Italy (V.P., L.F.)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"2026031201014627000_noaf247-B1","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jamaoncol.2018.1789","article-title":"Adult glioma incidence and survival by race or ethnicity in the United States from 2000 to 2014","volume":"4","author":"Ostrom","year":"2018","journal-title":"JAMA Oncol"},{"key":"2026031201014627000_noaf247-B2","doi-asserted-by":"crossref","first-page":"657953","DOI":"10.1155\/2014\/657953","article-title":"Salvage radiosurgery for selected patients with recurrent malignant gliomas","volume":"2014","author":"Mart\u00ednez-Carrillo","year":"2014","journal-title":"Biomed Res Int"},{"key":"2026031201014627000_noaf247-B3","first-page":"CD013579","article-title":"Treatment options for progression or recurrence of glioblastoma: a network meta-analysis","volume":"5","author":"McBain","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2026031201014627000_noaf247-B4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11060-018-03064-0","article-title":"Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis","volume":"142","author":"Kazmi","year":"2019","journal-title":"J Neurooncol"},{"key":"2026031201014627000_noaf247-B5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11060-023-04340-4","article-title":"Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis","volume":"163","author":"Moore-Palhares","year":"2023","journal-title":"J Neurooncol"},{"key":"2026031201014627000_noaf247-B6","first-page":"144","article-title":"Re-irradiation for recurrent high-grade gliomas: a systematic review and analysis of treatment technique with respect to survival and risk of radionecrosis","volume":"6","author":"Shanker","year":"2019","journal-title":"Neurooncol Pract"},{"key":"2026031201014627000_noaf247-B7","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1200\/JCO.22.00164","article-title":"NRG Oncology\/RTOG1205: a randomized phase II trial of concurrent bevacizumab and reirradiation versus bevacizumab alone as treatment for recurrent glioblastoma","volume":"41","author":"Tsien","year":"2023","journal-title":"J Clin Oncol"},{"key":"2026031201014627000_noaf247-B8","doi-asserted-by":"crossref","first-page":"652646","DOI":"10.3389\/fonc.2021.652646","article-title":"CyberKnife for recurrent malignant gliomas: a systematic review and meta-analysis","volume":"11","author":"De Maria","year":"2021","journal-title":"Front Oncol"},{"key":"2026031201014627000_noaf247-B9","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"2026031201014627000_noaf247-B10","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00066-014-0638-9","article-title":"Clinical radiobiology of glioblastoma multiforme: estimation of tumor control probability from various radiotherapy fractionation schemes","volume":"190","author":"Pedicini","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"2026031201014627000_noaf247-B11","author":"Higgins"},{"key":"2026031201014627000_noaf247-B12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.critrevonc.2017.03.005","article-title":"Radiosurgery for intracranial meningiomas: a systematic review and meta-analysis","volume":"113","author":"Pinzi","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"2026031201014627000_noaf247-B13","author":"Critical Appraisal Skills Programme","year":"2018"},{"key":"2026031201014627000_noaf247-B14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10014-012-0118-9","article-title":"Progressive adult primary glioblastoma in the medulla oblongata with an unmethylated MGMT promoter and without an IDH mutation","volume":"30","author":"Yoshikawa","year":"2013","journal-title":"Brain Tumor Pathol"},{"key":"2026031201014627000_noaf247-B15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11060-006-9231-0","article-title":"Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma","volume":"81","author":"Ernst-Stecken","year":"2007","journal-title":"J Neurooncol"},{"key":"2026031201014627000_noaf247-B16","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1002\/cncr.23402","article-title":"Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas","volume":"112","author":"Kong","year":"2008","journal-title":"Cancer"},{"key":"2026031201014627000_noaf247-B17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00701-011-1184-1","article-title":"Efficacy and toxicity of CyberKnife re-irradiation and \u201cdose dense\u201d temozolomide for recurrent gliomas","volume":"154","author":"Conti","year":"2012","journal-title":"Acta Neurochir (Wien)"},{"key":"2026031201014627000_noaf247-B18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11060-014-1634-8","article-title":"Outcome of radiosurgery for recurrent malignant gliomas: assessment of treatment response using relative cerebral blood volume","volume":"121","author":"Kim","year":"2015","journal-title":"J Neurooncol"},{"key":"2026031201014627000_noaf247-B19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11060-018-2988-0","article-title":"Gamma knife radiosurgery for recurrent gliomas","volume":"140","author":"Sadik","year":"2018","journal-title":"J Neurooncol"},{"key":"2026031201014627000_noaf247-B20","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.ijrobp.2024.01.013","article-title":"Prospective randomized phase 2 trial of hypofractionated stereotactic radiation therapy of 25 Gy in 5 fractions compared with 35 Gy in 5 fractions in the reirradiation of recurrent glioblastoma","volume":"119","author":"Chen","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026031201014627000_noaf247-B21","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.21873\/anticanres.13423","article-title":"Feasibility of salvage Re-irradiation with stereotactic radiotherapy for recurrent glioma using CyberKnife","volume":"39","author":"Adachi","year":"2019","journal-title":"Anticancer Res"},{"key":"2026031201014627000_noaf247-B22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/0973-1482.131403","article-title":"Fractionated stereotactic radiosurgery with volumetric modulated arc therapy (rapid arc) for reradiation in recurrent high grade gliomas","volume":"10","author":"Anand","year":"2014","journal-title":"J Cancer Res Ther"},{"key":"2026031201014627000_noaf247-B23","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.canrad.2016.03.006","article-title":"Patterns of relapse in patients with high grade glioma receiving combined treatments including stereotactic re-irradiation for a first relapse","volume":"20","author":"Antoni","year":"2016","journal-title":"Cancer Radiother"},{"key":"2026031201014627000_noaf247-B24","doi-asserted-by":"crossref","first-page":"19321","DOI":"10.1038\/s41598-020-75671-9","article-title":"Re-irradiation of recurrent glioblastoma using helical TomoTherapy with simultaneous integrated boost: preliminary considerations of treatment efficacy","volume":"10","author":"Arpa","year":"2020","journal-title":"Sci Rep"},{"key":"2026031201014627000_noaf247-B25","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10143-015-0632-4","article-title":"Factors predictive of improved overall survival following stereotactic radiosurgery for recurrent glioblastoma","volume":"38","author":"Bir","year":"2015","journal-title":"Neurosurg Rev"},{"key":"2026031201014627000_noaf247-B26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1748-717X-4-11","article-title":"Stereotactic radiosurgery for glioblastoma: retrospective analysis","volume":"4","author":"Biswas","year":"2009","journal-title":"Radiat Oncol"},{"key":"2026031201014627000_noaf247-B27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11060-021-03883-8","article-title":"Stereotactic radiosurgery for IDH wild type glioblastoma: an international, multicenter study","volume":"155","author":"Bunevicius","year":"2021","journal-title":"J Neurooncol"},{"key":"2026031201014627000_noaf247-B28","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3340\/jkns.2017.0259","article-title":"Efficacy of gamma knife radiosurgery for recurrent High-Grade gliomas with limited tumor volume","volume":"61","author":"Cheon","year":"2018","journal-title":"J Korean Neurosurg Soc"},{"key":"2026031201014627000_noaf247-B29","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0360-3016(99)00336-3","article-title":"Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas","volume":"45","author":"Cho","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026031201014627000_noaf247-B30","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s11060-019-03328-3","article-title":"Fractionated stereotactic radiosurgery for malignant gliomas: comparison with single session stereotactic radiosurgery","volume":"145","author":"Choi","year":"2019","journal-title":"J Neurooncol"},{"key":"2026031201014627000_noaf247-B31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/1748-717X-8-222","article-title":"Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience","volume":"8","author":"Ciammella","year":"2013","journal-title":"Radiat Oncol"},{"key":"2026031201014627000_noaf247-B32","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1002\/cncr.21429","article-title":"Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM)","volume":"104","author":"Combs","year":"2005","journal-title":"Cancer"},{"key":"2026031201014627000_noaf247-B33","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.ijrobp.2010.12.074","article-title":"Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas","volume":"82","author":"Cuneo","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026031201014627000_noaf247-B34","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1016\/j.wneu.2014.06.011","article-title":"Increased survival using delayed gamma knife radiosurgery for recurrent high-grade glioma: a feasibility study","volume":"82","author":"Dodoo","year":"2014","journal-title":"World Neurosurg"},{"key":"2026031201014627000_noaf247-B35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11060-020-03689-0","article-title":"Genomic alterations predictive of response to radiosurgery in recurrent IDH-WT glioblastoma","volume":"152","author":"Dono","year":"2021","journal-title":"J Neurooncol"},{"key":"2026031201014627000_noaf247-B36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.5301\/tj.5000236","article-title":"Management of patients with recurrent glioblastoma using hypofractionated stereotactic radiotherapy","volume":"101","author":"Dincoglan","year":"2015","journal-title":"Tumori"},{"key":"2026031201014627000_noaf247-B37","first-page":"1029","article-title":"Efficacy of stereotactic radiotherapy as salvage treatment for recurrent malignant gliomas","volume":"19","author":"Ekici","year":"2014","journal-title":"J Buon"},{"key":"2026031201014627000_noaf247-B38","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.wneu.2010.12.053","article-title":"Efficacy of gamma knife radiosurgery for small-volume recurrent malignant gliomas after initial radical resection","volume":"76","author":"Elliott","year":"2011","journal-title":"World Neurosurg"},{"key":"2026031201014627000_noaf247-B39","doi-asserted-by":"crossref","first-page":"E322","DOI":"10.1093\/neuros\/nyy520","article-title":"Patterns of failure after stereotactic radiosurgery for recurrent High-Grade glioma: a single institution experience of 10 years","volume":"85","author":"Ene","year":"2019","journal-title":"Neurosurgery"},{"key":"2026031201014627000_noaf247-B40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000448924","article-title":"Gamma knife radiosurgery in recurrent glioblastoma","volume":"94","author":"Frischer","year":"2016","journal-title":"Stereotact Funct Neurosurg"},{"key":"2026031201014627000_noaf247-B41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000493545","article-title":"Re-Irradiation with stereotactic radiosurgery\/radiotherapy for recurrent High-Grade gliomas: Improved survival in the modern era","volume":"96","author":"Gigliotti","year":"2018","journal-title":"Stereotact Funct Neurosurg"},{"key":"2026031201014627000_noaf247-B42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12885-021-07856-y","article-title":"Safety and efficacy of hypofractionated stereotactic radiosurgery for high-grade gliomas at first recurrence: a single-center experience","volume":"21","author":"Guan","year":"2021","journal-title":"BMC Cancer"},{"key":"2026031201014627000_noaf247-B43","first-page":"281","article-title":"Gamma knife radiosurgery for local recurrence of glioblastoma","volume":"39","author":"Guseynova","year":"2018","journal-title":"Neuro Endocrinol Lett"},{"key":"2026031201014627000_noaf247-B44","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1200\/JCO.1995.13.7.1642","article-title":"Stereotactic radiosurgery for recurrent malignant gliomas","volume":"13","author":"Hall","year":"1995","journal-title":"J Clin Oncol"},{"key":"2026031201014627000_noaf247-B45","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fonc.2015.00106","article-title":"Salvage fractionated stereotactic radiotherapy with or without chemotherapy and immunotherapy for recurrent glioblastoma multiforme: a single institution experience","volume":"5","author":"Hasan","year":"2015","journal-title":"Front Oncol"},{"key":"2026031201014627000_noaf247-B46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00066-009-1969-9","article-title":"Hypofractionated reirradiation for recurrent malignant glioma","volume":"185","author":"Henke","year":"2009","journal-title":"Strahlenther Onkol"},{"key":"2026031201014627000_noaf247-B47","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.4103\/0973-1482.199537","article-title":"Salvage stereotactic radiosurgery for recurrent glioblastoma multiforme with prior radiation therapy","volume":"12","author":"Holt","year":"2016","journal-title":"J Cancer Res Ther"},{"key":"2026031201014627000_noaf247-B48","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1227\/01.NEU.0000175550.96901.A3","article-title":"Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme","volume":"57","author":"Hsieh","year":"2005","journal-title":"Neurosurgery"},{"key":"2026031201014627000_noaf247-B49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1227\/NEU.0000000000001344","article-title":"Indications and efficacy of gamma knife stereotactic radiosurgery for recurrent glioblastoma: 2 decades of institutional experience","volume":"80","author":"Imber","year":"2017","journal-title":"Neurosurgery"},{"key":"2026031201014627000_noaf247-B50","first-page":"e18480","article-title":"Stereotactic radiosurgery for recurrent glioblastoma multiforme: a retrospective multi-institutional experience","volume":"13","author":"Lovo","year":"2021","journal-title":"Cureus"},{"key":"2026031201014627000_noaf247-B51","first-page":"291","article-title":"MRI tumor response and clinical outcomes after LINAC radiosurgery on 50 patients with recurrent malignant gliomas","volume":"2","author":"Khalil","year":"2013","journal-title":"J Radiosurg SBRT"},{"key":"2026031201014627000_noaf247-B52","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000163387","article-title":"Radiosurgery for intracranial gliomas","volume":"22","author":"Kida","year":"2009","journal-title":"Prog Neurol Surg"},{"key":"2026031201014627000_noaf247-B53","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1002\/cncr.27372","article-title":"Extended field stereotactic radiosurgery for recurrent glioblastoma","volume":"118","author":"Koga","year":"2012","journal-title":"Cancer"},{"key":"2026031201014627000_noaf247-B54","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/030089161109700111","article-title":"Treatment of recurrent glioblastoma with stereotactic radiotherapy: long-term results of a mono-institutional trial","volume":"97","author":"Maranzano","year":"2011","journal-title":"Tumori"},{"key":"2026031201014627000_noaf247-B55","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11060-013-1126-2","article-title":"Hypofractionated stereotactic radiotherapy for unifocal and multifocal recurrence of malignant gliomas","volume":"113","author":"McKenzie","year":"2013","journal-title":"J Neurooncol"},{"key":"2026031201014627000_noaf247-B56","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1748-717X-9-181","article-title":"Re-irradiation of recurrent glioblastoma multiforme using 11C-methionine PET\/CT\/MRI image fusion for hypofractionated stereotactic radiotherapy by intensity modulated radiation therapy","volume":"9","author":"Miwa","year":"2014","journal-title":"Radiat Oncol"},{"key":"2026031201014627000_noaf247-B57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4143\/crt.2014.259","article-title":"Hypofractionated stereotactic radiation therapy in recurrent High-Grade glioma: a new challenge","volume":"48","author":"Navarria","year":"2016","journal-title":"Cancer Res Treat"},{"key":"2026031201014627000_noaf247-B58","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3171\/2014.11.JNS13295","article-title":"Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era","volume":"122","author":"Niranjan","year":"2015","journal-title":"J Neurosurg"},{"key":"2026031201014627000_noaf247-B59","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11060-008-9752-9","article-title":"Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival","volume":"92","author":"Patel","year":"2009","journal-title":"J Neurooncol"},{"key":"2026031201014627000_noaf247-B60","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s10072-015-2172-7","article-title":"Radiosurgery reirradiation for high-grade glioma recurrence: a retrospective analysis","volume":"36","author":"Pinzi","year":"2015","journal-title":"Neurol Sci"},{"key":"2026031201014627000_noaf247-B61","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11060-009-9873-9","article-title":"Gamma knife radiosurgery after radiation therapy as an adjunctive treatment for glioblastoma","volume":"94","author":"Pouratian","year":"2009","journal-title":"J Neurooncol"},{"key":"2026031201014627000_noaf247-B62","first-page":"e6527","article-title":"Stereotactic radiosurgery for the treatment of recurrent high-grade gliomas: long-term follow-up","volume":"11","author":"Sallabanda","year":"2019","journal-title":"Cureus"},{"key":"2026031201014627000_noaf247-B63","doi-asserted-by":"crossref","first-page":"3e12","DOI":"10.1023\/A:1009564917990","article-title":"Hypofractionated stereotactic radiotherapy for recurrent malignant gliomas","volume":"3","author":"Selch","year":"2000","journal-title":"J Radiosurg"},{"key":"2026031201014627000_noaf247-B64","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3171\/2018.4.JNS172909","article-title":"Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery","volume":"131","author":"Sharma","year":"2019","journal-title":"J Neurosurg"},{"key":"2026031201014627000_noaf247-B65","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1227\/00006123-199502000-00006","article-title":"Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme","volume":"36","author":"Shrieve","year":"1995","journal-title":"Neurosurgery"},{"key":"2026031201014627000_noaf247-B66","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2298\/VSP1111961S","article-title":"Linear accelerator-based stereotactic radiosurgery in recurrent glioblastoma: a single center experience","volume":"68","author":"Sirin","year":"2011","journal-title":"Vojnosanit Pregl"},{"key":"2026031201014627000_noaf247-B67","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.wneu.2012.03.024","article-title":"\u03b3 knife surgery versus reoperation for recurrent glioblastoma multiforme","volume":"78","author":"Skeie","year":"2012","journal-title":"World Neurosurg"},{"key":"2026031201014627000_noaf247-B68","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.2217\/fon-2017-0226","article-title":"Salvage stereotactic radiosurgery for recurrent gliomas with prior radiation therapy","volume":"13","author":"Sutera","year":"2017","journal-title":"Future Oncol"},{"key":"2026031201014627000_noaf247-B69","doi-asserted-by":"crossref","first-page":"253","DOI":"10.7785\/tcrt.2012.500200","article-title":"Re-irradiation with radiosurgery for recurrent glioblastoma multiforme","volume":"10","author":"Torok","year":"2011","journal-title":"Technol Cancer Res Treat"},{"key":"2026031201014627000_noaf247-B70","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10143-009-0212-6","article-title":"Survival following stereotactic radiosurgery for newly diagnosed and recurrent glioblastoma multiforme: a multicenter experience","volume":"32","author":"Villavicencio","year":"2009","journal-title":"Neurosurg Rev"},{"key":"2026031201014627000_noaf247-B71","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000505706","article-title":"Stereotactic radiotherapy in recurrent glioblastoma: a valid salvage treatment option","volume":"98","author":"Yaprak","year":"2020","journal-title":"Stereotact Funct Neurosurg"},{"key":"2026031201014627000_noaf247-B72","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11060-014-1524-0","article-title":"Hypofractionated stereotactic reirradiation for recurrent glioblastoma","volume":"120","author":"Yazici","year":"2014","journal-title":"J Neurooncol"},{"key":"2026031201014627000_noaf247-B73","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1017\/S0317167100015894","article-title":"Gamma knife radiosurgery for high grade glial neoplasms: a Canadian experience","volume":"40","author":"Zeiler","year":"2013","journal-title":"Can J Neurol Sci"},{"key":"2026031201014627000_noaf247-B74","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/ane.12719","article-title":"Prognostic parameters and outcome after re-irradiation for progressive glioblastoma","volume":"136","author":"Zwirner","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"2026031201014627000_noaf247-B75","doi-asserted-by":"crossref","first-page":"361","DOI":"10.5603\/RPOR.a2023.0034","article-title":"Re-irradiation with stereotactic radiotherapy for recurrent high-grade glial tumors","volume":"28","author":"Soykut","year":"2023","journal-title":"Rep Pract Oncol Radiother"},{"key":"2026031201014627000_noaf247-B76","author":"Oxford Centre for Evidence-Based Medicine. Levels of Evidence","year":"2009"},{"key":"2026031201014627000_noaf247-B77","volume-title":"Advances in Patient Safety: From Research to Implementation","author":"K","year":"2005"},{"key":"2026031201014627000_noaf247-B78","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijrobp.2023.07.015","article-title":"A systematic review informing the management of symptomatic brain radiation necrosis after stereotactic radiosurgery and international stereotactic radiosurgery society recommendations","volume":"118","author":"Vellayappan","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026031201014627000_noaf247-B79","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.prro.2022.10.013","article-title":"ISRS technical guidelines for stereotactic radiosurgery: treatment of small brain metastases (\u22641 cm in diameter)","volume":"13","author":"Grishchuk","year":"2023","journal-title":"Pract Radiat Oncol"},{"key":"2026031201014627000_noaf247-B80","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/ijms24010408","article-title":"A comparison of PET tracers in recurrent High-Grade gliomas: a systematic review","volume":"24","author":"Muthukumar","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026031201014627000_noaf247-B81","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1186\/s12885-016-2806-z","article-title":"Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) \u2013 protocol of a randomized phase II trial (NOA 10\/ARO 2013-1)","volume":"16","author":"Oehlke","year":"2016","journal-title":"BMC Cancer"},{"key":"2026031201014627000_noaf247-B82","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13014-021-01767-9","article-title":"Current status and recent advances in reirradiation of glioblastoma","volume":"16","author":"Minniti","year":"2021","journal-title":"Radiat Oncol"},{"key":"2026031201014627000_noaf247-B83","doi-asserted-by":"crossref","first-page":"8863","DOI":"10.1200\/JCO.2005.03.4157","article-title":"Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution","volume":"23","author":"Combs","year":"2005","journal-title":"J Clin Oncol"},{"key":"2026031201014627000_noaf247-B84","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11060-015-1825-y","article-title":"Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better","volume":"124","author":"Palmer","year":"2015","journal-title":"J Neurooncol"},{"key":"2026031201014627000_noaf247-B85","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s11060-017-2611-9","article-title":"Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone","volume":"135","author":"Arvold","year":"2017","journal-title":"J Neurooncol"},{"key":"2026031201014627000_noaf247-B86","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s11060-019-03320-x","article-title":"Longitudinal analysis of quality of life following treatment with asunercept plus reirradiation versus reirradiation in progressive glioblastoma patients","volume":"145","author":"Wick","year":"2019","journal-title":"J Neurooncol"},{"key":"2026031201014627000_noaf247-B87","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ijrobp.2017.06.2466","article-title":"Multicenter, phase 1, dose escalation study of hypofraction- ated stereotactic radiation therapy with bevacizumab for recurrent glioblastoma and anaplastic astrocytoma","volume":"99","author":"Clarke","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026031201014627000_noaf247-B88","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ijrobp.2013.04.029","article-title":"Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trial","volume":"86","author":"Cabrera","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026031201014627000_noaf247-B89","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11060-012-0999-9","article-title":"Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas","volume":"111","author":"Minniti","year":"2013","journal-title":"J Neurooncol"},{"key":"2026031201014627000_noaf247-B90","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/oncolo\/oyad095","article-title":"Hypofractionated stereotactic Re-irradiation and anti-PDL1 durvalumab combination in recurrent glioblastoma: STERIMGLI phase I results","volume":"28","author":"Pouessel","year":"2023","journal-title":"Oncologist"},{"key":"2026031201014627000_noaf247-B91","doi-asserted-by":"crossref","first-page":"ii36","DOI":"10.1093\/neuonc\/noaa215.149","article-title":"Ctim-15. PRELIMINARY results of a phase ii study of nivolumab with hypofractionated re-radiation and bevacizumab for recurrent mgmt methylated glioblastoma","volume":"22","author":"Rommes","year":"2020","journal-title":"Neuro-Oncology"},{"key":"2026031201014627000_noaf247-B92","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/neuonc\/noaa260","article-title":"Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study","volume":"23","author":"Sahebjam","year":"2021","journal-title":"Neuro Oncol"},{"key":"2026031201014627000_noaf247-B93","author":"Bagley","year":"2023"},{"key":"2026031201014627000_noaf247-B94","first-page":"vdaf033","article-title":"Phase 1 trial of hypofractionated stereotactic re-irradiation in combination with nivolumab, ipilimumab, and bevacizumab for recurrent high-grade gliomas","volume":"7","author":"Sahebjam","year":"2025","journal-title":"Neurooncol Adv"},{"key":"2026031201014627000_noaf247-B95","doi-asserted-by":"crossref","first-page":"vii64","DOI":"10.1093\/neuonc\/noac209.253","article-title":"CTIM-21. NRG-bn010: a safety run-in and phase II study evaluating the combination of tocilizumab, atezolizumab, and fractionated stereotactic radiotherapy in recurrent glioblastoma \u2013 trial in progress","volume":"24","author":"Bagley","year":"2022","journal-title":"Neuro-Oncology."},{"key":"2026031201014627000_noaf247-B96","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.semradonc.2008.04.005","article-title":"The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery","volume":"18","author":"Kirkpatrick","year":"2008","journal-title":"Semin Radiat Oncol"},{"key":"2026031201014627000_noaf247-B97","doi-asserted-by":"crossref","first-page":"i76","DOI":"10.1093\/jrr\/rrw015","article-title":"Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?","volume":"57 Suppl 1","author":"Shibamoto","year":"2016","journal-title":"J Radiat Res"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noaf247\/64956443\/noaf247.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/28\/2\/353\/64956443\/noaf247.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/28\/2\/353\/64956443\/noaf247.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:02:02Z","timestamp":1773291722000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/28\/2\/353\/8303919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":97,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,10,27]]},"published-print":{"date-parts":[[2026,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noaf247","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,10,27]]}}}